CN104206597A - 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 - Google Patents
一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 Download PDFInfo
- Publication number
- CN104206597A CN104206597A CN201410453743.4A CN201410453743A CN104206597A CN 104206597 A CN104206597 A CN 104206597A CN 201410453743 A CN201410453743 A CN 201410453743A CN 104206597 A CN104206597 A CN 104206597A
- Authority
- CN
- China
- Prior art keywords
- parts
- lung
- fruit
- kidney
- deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000006079 Schisandra chinensis Species 0.000 title claims abstract description 116
- 230000036541 health Effects 0.000 title claims abstract description 37
- 208000024891 symptom Diseases 0.000 title claims abstract description 34
- 235000008422 Schisandra chinensis Nutrition 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 20
- 210000004072 lung Anatomy 0.000 title abstract description 136
- 210000003734 kidney Anatomy 0.000 title abstract description 106
- 208000031971 Yin Deficiency Diseases 0.000 title abstract description 25
- 244000269722 Thea sinensis Species 0.000 title abstract 5
- 244000062939 Leptospermum ericoides Species 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 18
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 230000007812 deficiency Effects 0.000 claims description 114
- 235000013399 edible fruits Nutrition 0.000 claims description 110
- 239000003814 drug Substances 0.000 claims description 109
- 229940079593 drug Drugs 0.000 claims description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 241001122767 Theaceae Species 0.000 claims description 29
- 230000008901 benefit Effects 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 17
- 244000003416 Asparagus officinalis Species 0.000 claims description 16
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 16
- 239000009636 Huang Qi Substances 0.000 claims description 15
- 235000008708 Morus alba Nutrition 0.000 claims description 14
- 240000000249 Morus alba Species 0.000 claims description 14
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 14
- 241000208966 Polygala Species 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 14
- 241000830535 Ligustrum lucidum Species 0.000 claims description 13
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 239000012535 impurity Substances 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 230000002829 reductive effect Effects 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- 235000012907 honey Nutrition 0.000 claims description 7
- 241000238631 Hexapoda Species 0.000 claims description 6
- 241000607479 Yersinia pestis Species 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000004575 stone Substances 0.000 claims description 6
- 235000011837 pasties Nutrition 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 230000000249 desinfective effect Effects 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000005057 refrigeration Methods 0.000 claims description 4
- 238000000967 suction filtration Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 206010011224 Cough Diseases 0.000 abstract description 97
- 230000000694 effects Effects 0.000 abstract description 40
- 210000004185 liver Anatomy 0.000 abstract description 22
- 235000019640 taste Nutrition 0.000 abstract description 12
- 208000000059 Dyspnea Diseases 0.000 abstract description 11
- 206010013975 Dyspnoeas Diseases 0.000 abstract description 11
- 239000000796 flavoring agent Substances 0.000 abstract description 11
- 235000019634 flavors Nutrition 0.000 abstract description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 5
- 239000010931 gold Substances 0.000 abstract description 5
- 229910052737 gold Inorganic materials 0.000 abstract description 5
- 230000001976 improved effect Effects 0.000 abstract description 4
- 241000759833 Cornus officinalis Species 0.000 abstract description 2
- 241001080798 Polygala tenuifolia Species 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000084791 Curculigo orchioides Species 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 241001633680 Polygonatum odoratum Species 0.000 abstract 1
- 241000037831 Polygonatum sibiricum Species 0.000 abstract 1
- 241001121987 Scrophularia ningpoensis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 49
- 201000010099 disease Diseases 0.000 description 47
- 206010062717 Increased upper airway secretion Diseases 0.000 description 38
- 208000026435 phlegm Diseases 0.000 description 38
- 239000007789 gas Substances 0.000 description 33
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 24
- 208000011580 syndromic disease Diseases 0.000 description 22
- 210000000952 spleen Anatomy 0.000 description 21
- 210000001124 body fluid Anatomy 0.000 description 20
- 239000010839 body fluid Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 206010037660 Pyrexia Diseases 0.000 description 13
- 206010029410 night sweats Diseases 0.000 description 13
- 230000036565 night sweats Effects 0.000 description 13
- 230000002269 spontaneous effect Effects 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 230000035922 thirst Effects 0.000 description 11
- 230000009286 beneficial effect Effects 0.000 description 10
- 210000000056 organ Anatomy 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 9
- 241000411851 herbal medicine Species 0.000 description 9
- 230000003902 lesion Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000011800 void material Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 206010036790 Productive cough Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- 210000001835 viscera Anatomy 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010013954 Dysphoria Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 7
- 208000013116 chronic cough Diseases 0.000 description 7
- 210000003127 knee Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 206010036067 polydipsia Diseases 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 210000003802 sputum Anatomy 0.000 description 7
- 208000024794 sputum Diseases 0.000 description 7
- 210000003462 vein Anatomy 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 231100000862 numbness Toxicity 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 208000017574 dry cough Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 201000001881 impotence Diseases 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000021251 pulses Nutrition 0.000 description 5
- 230000001603 reducing effect Effects 0.000 description 5
- 210000004243 sweat Anatomy 0.000 description 5
- 231100001274 therapeutic index Toxicity 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 206010049865 Achromotrichia acquired Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 206010061245 Internal injury Diseases 0.000 description 4
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000001647 Renal Insufficiency Diseases 0.000 description 4
- 240000008866 Ziziphus nummularia Species 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 229930013686 lignan Natural products 0.000 description 4
- 235000009408 lignans Nutrition 0.000 description 4
- 150000005692 lignans Chemical class 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 206010006458 Bronchitis chronic Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010013789 Dry throat Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010014561 Emphysema Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000037656 Respiratory Sounds Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 241000282806 Rhinoceros Species 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 208000007451 chronic bronchitis Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 229930193195 schizandrin Natural products 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 3
- 210000000216 zygoma Anatomy 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000208365 Celastraceae Species 0.000 description 2
- 201000006306 Cor pulmonale Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010036018 Pollakiuria Diseases 0.000 description 2
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 235000000336 Solanum dulcamara Nutrition 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010047924 Wheezing Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000020965 cold beverage Nutrition 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 2
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000007420 reactivation Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008085 renal dysfunction Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 230000035946 sexual desire Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000016790 Allium chinense Nutrition 0.000 description 1
- 244000295724 Allium chinense Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 244000141006 Armeniaca sibirica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 235000017965 Asarum canadense Nutrition 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 240000006063 Averrhoa carambola Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- 235000000385 Costus speciosus Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241001252483 Kalimeris Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 240000002547 Rosa roxburghii Species 0.000 description 1
- 235000000640 Rosa roxburghii Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000606265 Valeriana jatamansi Species 0.000 description 1
- 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000009798 acute exacerbation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000003262 anti-osteoporosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000020639 clam Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010064 diabetes insipidus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229940085771 feverall Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000036649 mental concentration Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000001260 vocal cord Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 例数 | 临床痊愈 | 显效 | 有效 | 无效 | 总有效 |
缓解组 | 80 | 45(56.25) | 21(26.25) | 12(15) | 2(2.5) | 97.5Δ |
对照组 | 80 | 33(41.25) | 17(21.25) | 14(17.5) | 16(20) | 80 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410453743.4A CN104206597B (zh) | 2014-09-05 | 2014-09-05 | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410453743.4A CN104206597B (zh) | 2014-09-05 | 2014-09-05 | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104206597A true CN104206597A (zh) | 2014-12-17 |
CN104206597B CN104206597B (zh) | 2016-08-24 |
Family
ID=52088814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410453743.4A Active CN104206597B (zh) | 2014-09-05 | 2014-09-05 | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104206597B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104686764A (zh) * | 2015-03-23 | 2015-06-10 | 万雄集团股份有限公司 | 一种改善女性更年期症状的咖啡饮料及其制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007028997A (ja) * | 2005-07-27 | 2007-02-08 | Kanebo Seiyaku Kk | 生薬エキス配合流動食及びその使用 |
CN101138369A (zh) * | 2006-09-06 | 2008-03-12 | 蔡如桂 | 一种消渴茶 |
CN101617820A (zh) * | 2008-07-03 | 2010-01-06 | 陈磊 | 一种强心保健茶 |
CN102895432A (zh) * | 2011-07-26 | 2013-01-30 | 王登之 | 开心散新剂型处方工艺及其制备方法 |
CN102911831A (zh) * | 2011-08-03 | 2013-02-06 | 葛双铭 | 滋补葡萄酒 |
CN103656164A (zh) * | 2012-09-20 | 2014-03-26 | 天津中新药业集团股份有限公司隆顺榕制药厂 | 一种滋阴养血补心安神的中药组合物及其制备方法 |
CN103719498A (zh) * | 2013-12-31 | 2014-04-16 | 青岛恒波仪器有限公司 | 一种提高免疫力的黄精保健茶及其制备方法 |
CN103734428A (zh) * | 2013-12-31 | 2014-04-23 | 青岛恒波仪器有限公司 | 一种提高免疫力的女贞子保健茶及其制备方法 |
CN103749820A (zh) * | 2013-12-31 | 2014-04-30 | 青岛恒波仪器有限公司 | 一种清肝明目的炒青葙子茶及其制备方法 |
-
2014
- 2014-09-05 CN CN201410453743.4A patent/CN104206597B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007028997A (ja) * | 2005-07-27 | 2007-02-08 | Kanebo Seiyaku Kk | 生薬エキス配合流動食及びその使用 |
CN101138369A (zh) * | 2006-09-06 | 2008-03-12 | 蔡如桂 | 一种消渴茶 |
CN101617820A (zh) * | 2008-07-03 | 2010-01-06 | 陈磊 | 一种强心保健茶 |
CN102895432A (zh) * | 2011-07-26 | 2013-01-30 | 王登之 | 开心散新剂型处方工艺及其制备方法 |
CN102911831A (zh) * | 2011-08-03 | 2013-02-06 | 葛双铭 | 滋补葡萄酒 |
CN103656164A (zh) * | 2012-09-20 | 2014-03-26 | 天津中新药业集团股份有限公司隆顺榕制药厂 | 一种滋阴养血补心安神的中药组合物及其制备方法 |
CN103719498A (zh) * | 2013-12-31 | 2014-04-16 | 青岛恒波仪器有限公司 | 一种提高免疫力的黄精保健茶及其制备方法 |
CN103734428A (zh) * | 2013-12-31 | 2014-04-23 | 青岛恒波仪器有限公司 | 一种提高免疫力的女贞子保健茶及其制备方法 |
CN103749820A (zh) * | 2013-12-31 | 2014-04-30 | 青岛恒波仪器有限公司 | 一种清肝明目的炒青葙子茶及其制备方法 |
Non-Patent Citations (2)
Title |
---|
曹焯 等: "北五味子复合保健茶的研制", 《黑龙江农业科学》 * |
郭桃美 等: "《肾病验方》", 30 April 2002, 广东科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104686764A (zh) * | 2015-03-23 | 2015-06-10 | 万雄集团股份有限公司 | 一种改善女性更年期症状的咖啡饮料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104206597B (zh) | 2016-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988638B (zh) | 一种青钱柳叶降脂降糖保健茶及其制备方法 | |
CN103719498B (zh) | 一种提高免疫力的黄精保健茶及其制备方法 | |
CN102669366A (zh) | 一种护肝润肺茶及其制备方法 | |
CN104305205B (zh) | 一种提高免疫力的菟丝子口服液及其制备方法 | |
CN103719491B (zh) | 一种黄精健脾润肺保健茶及其制备方法 | |
CN104365943A (zh) | 一种降糖降脂的槐角茶及其制备方法 | |
CN103749821B (zh) | 一种提高免疫力的绞股蓝保健茶及其制备方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN104472789A (zh) | 一种润肠通便的槐角茶及其制备方法 | |
CN103749824A (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN104304602A (zh) | 一种软化血管的槐角茶及其制备方法 | |
CN104286864B (zh) | 一种提高免疫力的沙苑子口服液及其制备方法 | |
CN103719496B (zh) | 一种山楂叶降脂减肥保健茶及其制备方法 | |
CN105341944A (zh) | 一种提高免疫力的丹参口服液及其制备方法 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN105394282A (zh) | 一种可降压降糖降脂的葛根保健茶 | |
CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 | |
CN104957515A (zh) | 一种辅助降血糖的馒头及其制备方法 | |
CN104258224A (zh) | 一种治疗肺肾阴虚型慢性支气管炎的五味子口服液及其制备方法 | |
CN104206597B (zh) | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 | |
CN106177540A (zh) | 一种清热止痛的蒲公英口服液及其制备方法 | |
CN105455125A (zh) | 一种提高免疫力的龙眼肉口服液及其制备方法 | |
CN104223062B (zh) | 一种降压降糖的地骨皮保健口服液及其制备方法 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160712 Address after: Qingdao City, Shandong province 266033 Taiwan Liu Road No. 138 B Applicant after: Yang Gaolin Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Applicant before: Qingdao Hengbo Instrument Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191010 Address after: 314500, building 288, 2 Avenue, Indus street, Tongxiang, Zhejiang, Jiaxing Patentee after: Zhejiang harvest Network Technology Co., Ltd. Address before: Qingdao City, Shandong province 266033 Taiwan Liu Road No. 138 B Patentee before: Yang Gao Lin |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191023 Address after: Room 1025-55, Xinfeng building, No. 45, Runfeng Pedestrian Street East, Wutong street, Tongxiang City, Jiaxing City, Zhejiang Province Patentee after: Jiaxing Jiming Trading Co., Ltd. Address before: 314500, building 288, 2 Avenue, Indus street, Tongxiang, Zhejiang, Jiaxing Patentee before: Zhejiang harvest Network Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200316 Address after: 610000 Longjing North Street, Wuhou District cluster bridge street, Chengdu, Sichuan, 190 Patentee after: SICHUAN SHENGMINGYUAN HEALTH MANAGEMENT Co.,Ltd. Address before: Room 1025-55, Xinfeng building, No. 45, Runfeng Pedestrian Street East, Wutong street, Tongxiang City, Jiaxing City, Zhejiang Province Patentee before: JIAXING JIMING COMMERCE AND TRADE Co.,Ltd. |
|
TR01 | Transfer of patent right |